Zobrazeno 1 - 10
of 59
pro vyhledávání: ''
Autor:
Eldad J. Dann, Ronit Gurion, Tamar Tadmor, Tatiana Mashiach, Estherina Trachtenberg, Meirav Kedmi
Publikováno v:
Leukemia & Lymphoma. 60:3449-3454
Hodgkin lymphoma (HL) is common in young adults and considered curable in most patients. Young HL survivors (HLS) are at risk of long-term adverse effects. Our study aimed to assess various fatigue and quality of life (QoL) complaints, and their corr
Autor:
Hubert H. Chuang, Chelsea C. Pinnix, Donald Hancock, N. George Mikhaeel, Sarah A. Milgrom, Andrew Wirth, Michalis Aristophanous, Mary Pham, Loretta J. Nastoupil, Bouthaina S. Dabaja, Yasuhiro Oki, Ethan B. Ludmir, Michelle A. Fanale, T.Y. Andraos, Jillian R. Gunther
Publikováno v:
Leukemia & Lymphoma. 59:2650-2659
Cardiophrenic lymph nodes (CPLNs) are occasionally involved in Hodgkin lymphoma (HL). We characterized the incidence of CPLN involvement among 169 HL patients and evaluated outcomes after treatment with omission of the CPLN region from the involved-s
Autor:
Vijayveer Bonthapally, Akshara Richhariya, Jeremy Teasell, Shih-Yuan Lee, Ashish Gautam, Yanyan Zhu, Esprit Ma, Dirk Huebner, Erin Zagadailov
Publikováno v:
Leukemia & Lymphoma. 59:69-76
The number needed to treat (NNT) with brentuximab vedotin consolidation therapy post-autologous stem cell transplant (ASCT) versus placebo in the phase 3 AETHERA trial to avoid one additional event of disease progression/death was evaluated. AETHERA
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma
Autor:
Vishal Kukreti, Theodore K. Marras, Richard W. Tsang, Michael Crump, John Kuruvilla, Eshetu G. Atenafu, Haowei Linda Sun
Publikováno v:
Leukemia & Lymphoma. 58:2607-2614
Bleomycin pulmonary toxicity (BPT) is a well-described complication of bleomycin-containing regimens. Previous data on risk factors and the impact of BPT on survival in Hodgkin lymphoma (HL) were conflicting. We reviewed 253 HL patients treated with
Autor:
Merav Leiba, Yael Bar Zeev, Lital Keinan-Boker, Jeremy D. Kark, Adi Leiba, Hagai Levine, Estela Derazne
Publikováno v:
Leukemia & Lymphoma. 58:959-968
Hodgkin Lymphoma (HL), a common early adulthood malignancy, has a complex etiology. We conducted a migrant cohort study to assess immigration status and origin as predictors of HL in Israel, which has among the highest rates of HL worldwide. Nationwi
Autor:
Paul Hoskins, Joseph M. Connors, Graham W. Slack, Randy D. Gascoyne, Tamara Shenkier, Kerry J. Savage, Alden A. Moccia, Maryse M. Power, Kevin W. Song, Laurie H. Sehn, Felicitas Hitz, John D. Shepherd, Richard Klasa
Publikováno v:
Leukemia & Lymphoma. 58:324-332
The optimal choice of salvage therapy for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) or Hodgkin lymphoma (HL) remains unknown. Based on promising results of phase II trials, the preferred salvage regimen in British Columb
Autor:
Graham W. Slack, Edward G. Brooks, Richard Klasa, Laurie H. Sehn, Diego Villa, Randy D. Gascoyne, Tamara Shenkier, Joseph M. Connors, Alina S. Gerrie, Kerry J. Savage, Brian Skinnider
Publikováno v:
Leukemia & Lymphoma. 57:872-879
The impact of treatment delays on outcomes in Hodgkin lymphoma (HL) is currently unknown. Time from definitive histologic diagnosis to first ABVD treatment (TDT) was calculated in 810 adults with HL: 365 (45%) TDT ≤4 weeks, 369 (46%) TDT 5-8 weeks,
Publikováno v:
Leukemia & Lymphoma. 56:3143-3149
The current study aimed to assess the economic burden of progressive disease among patients with Hodgkin lymphoma (HL) receiving second- or third-line therapy in a large US network of community-based practices. This retrospective, observational cohor
Autor:
Carmen Fernandez-Alvarez, Arturo Rubio-Castro, Ana P Gonzalez-Rodriguez, Jackeline Solano, Ruben Fernández-Álvarez, Angel Ramirez Payer, Jesus E. Medina, Jose Manuel Alonso, M. Esther Gonzalez, Yahya Zanabili, Eva Alonso-Nogues, José Vicente, Juan M. Sancho, Francisco Dominguez-Iglesias
Publikováno v:
Leukemia & Lymphoma. 56:3096-3102
Ferritin levels might correlate with disease activity in classical Hodgkin lymphoma (cHL). We analyzed the prognostic significance of the ferritin value at diagnosis in 173 cHL patients treated with ABVD between 2003 and 2013. The 5-year overall surv
Autor:
Sheila Aparecida Coelho Siqueira, Marianne de Castro Gonçalves, Maria Claudia Nogueira Zerbini, Vera Lucia Aldred, Henrique Moura de Paula, Juliano Julio Cerci, Valeria Buccheri, Camila da Cruz Gouveia Linardi
Publikováno v:
Leukemia & Lymphoma. 56:2883-2888
Bone marrow biopsy is recommended for staging of classical Hodgkin lymphoma. The aim of this study was to compare bone marrow evaluation by histology with that obtained by (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET). One hundred a